Why don't antibiotics help acute bronchitis?
Acute bronchitis is an inflammation of the airways, and in over 90% of cases in healthy adults, it is caused by a virus — not bacteria [3]. Antibiotics only kill bacteria, so they have no direct effect on the viral infection driving the illness. The most comprehensive analysis available, a 2017 Cochrane review pooling 17 randomized controlled trials with over 5,000 patients, found that antibiotics did not increase the number of patients who felt clinically improved [6]. In a more recent 2013 trial of 416 adults with acute bronchitis and discolored sputum (often mistakenly thought to indicate a bacterial infection), treatment with the antibiotic amoxicillin-clavulanic acid did not shorten the duration of cough compared to placebo — both groups coughed for a median of 11 days [1]. This directly shows that even green or yellow phlegm does not mean antibiotics will help.
Are there any benefits, and what are the risks?
The evidence does show a very small, statistically significant benefit from antibiotics, but it is so modest that it is unlikely to matter to most patients. The Cochrane review found that antibiotics shortened the average duration of cough by about half a day (0.46 days) and reduced the number of days feeling ill by about two-thirds of a day (0.64 days) [6]. However, this tiny gain comes with real downsides. The same review found that antibiotics increased the risk of adverse effects — such as nausea, diarrhea, or rash — by 20%, meaning that for every 24 people treated, one extra person will experience a side effect [6]. A 2013 trial confirmed that side effects were significantly more common with antibiotics (12%) than with placebo (3%) [1]. Furthermore, unnecessary antibiotic use fuels the global crisis of antibiotic resistance, making these drugs less effective for everyone in the future [4][5].
What actually works for acute bronchitis?
Since antibiotics are not the answer, the focus should be on symptom relief while the body clears the virus. Several studies in this collection show that non-antibiotic treatments can be effective. A 2023 trial found that inhaled 7% hypertonic saline (a saltwater solution) significantly reduced cough severity: by day 4, 64% of patients using it had a major reduction in cough, compared to only 32% in the control group [3]. Herbal and anti-inflammatory options also show promise. A 2022 trial of the herbal formula GHX02 in 117 patients found it significantly improved bronchitis symptoms (measured by the Bronchitis Severity Score) compared to placebo [2]. Another 2013 trial found that the anti-inflammatory drug ibuprofen led to a slightly shorter cough duration (9 days) than either antibiotics (11 days) or placebo (11 days), though this difference was not statistically significant [1]. These options provide real symptom relief without the risks of antibiotics.
About These Sources
This answer is built on 6 peer-reviewed studies — published from 2013 to 2023, 1 in Q1 journals — selected as the most relevant from 14 studies that passed quality screening, drawn from 61 papers retrieved from a database of over 500 million.
Sources used in this answer
Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial.
In a randomized trial of 416 adults with acute bronchitis and discolored sputum, neither the antibiotic amoxicillin-clavulanic acid nor the anti-inflammatory ibuprofen shortened cough duration compared to placebo (median 11, 11, and 11 days respectively). Side effects were more common with antibiotics (12% vs 3% placebo).
Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
In a phase II randomized trial of 117 patients with acute bronchitis or acute exacerbation of chronic bronchitis, the herbal formula GHX02 significantly improved the Bronchitis Severity Score compared to placebo (mean change 4.2-4.5 vs 3.8 points) with no serious adverse effects.
Clinical efficacy of mucoactive therapy with 7% hypertonic saline in patients with acute bronchitis
In a trial of 50 adults with acute bronchitis, inhaled 7% hypertonic saline led to a more pronounced reduction in cough severity by day 4 compared to standard mucoactive therapy (64% vs 32% of patients had major improvement).
Operationalising outpatient antimicrobial stewardship to reduce system-wide antibiotics for acute bronchitis
A quality improvement project in VA outpatient clinics reduced antibiotic prescribing for acute bronchitis from 64.6% to 36.8% through antimicrobial stewardship interventions, with no increase in return visits or phone calls.
2210. Reducing Inappropriate Antibiotic Prescribing for Acute Uncomplicated Bronchitis
A retrospective study of 8,176 outpatient encounters found that an antimicrobial stewardship intervention bundle significantly reduced inappropriate antibiotic prescribing for bronchitis from 44.9% to 32.5%.
Antibiotics for acute bronchitis.
This Cochrane review of 17 trials (5,099 participants) found that antibiotics for acute bronchitis produced only a modest benefit (cough shortened by ~0.5 days) but increased side effects (number needed to harm = 24). The authors concluded there is limited evidence of clinical benefit.